Chadrick Denlinger to Antineoplastic Agents
This is a "connection" page, showing publications Chadrick Denlinger has written about Antineoplastic Agents.
Connection Strength
0.649
-
Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2021 08; 162(2):463-473.
Score: 0.419
-
Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis. Ann Thorac Surg. 2004 Oct; 78(4):1207-14; discussion 1207-14.
Score: 0.142
-
Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer. Surgery. 2005 Aug; 138(2):360-7.
Score: 0.037
-
Modulation of antiapoptotic cell signaling pathways in non-small cell lung cancer: the role of NF-kappaB. Semin Thorac Cardiovasc Surg. 2004; 16(1):28-39.
Score: 0.034
-
Novel targeted therapies for non-small cell lung cancer. Thorac Surg Clin. 2006 Nov; 16(4):353-66.
Score: 0.010
-
Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway. J Biol Chem. 2003 May 23; 278(21):18980-9.
Score: 0.008